SHORT BOWEL SYNDROME
Clinical trials for SHORT BOWEL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SHORT BOWEL SYNDROME trials appear
Sign up with your email to follow new studies for SHORT BOWEL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope to reduce lifelong IV dependence for gut failure patients
Disease control Recruiting nowThis study is testing whether a new injectable medication called glepaglutide can help adults with short bowel syndrome reduce their need for intravenous (IV) nutrition and fluids. About 90 participants will receive either the real drug or a placebo injection twice a week to see …
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New device aims to free kids from IV feeding tubes
Disease control Recruiting nowThis study is testing a small cartridge called RELiZORB that attaches to a feeding tube. It's designed to help children with short bowel syndrome digest and absorb fats from their tube feeding. The goal is to see if better nutrient absorption can reduce or eliminate the child's n…
Matched conditions: SHORT BOWEL SYNDROME
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New device aims to grow intestines for patients with short bowel syndrome
Disease control Recruiting nowThis study is testing a new medical device called the Eclipse XL1 System. It is designed to be placed inside the intestine to gently stretch and lengthen it over time in patients with short bowel syndrome. The main goals are to see if the device is safe and if it helps improve pa…
Matched conditions: SHORT BOWEL SYNDROME
Phase: NA • Sponsor: Eclipse Regenesis, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New injection tested for rare gut condition that requires IV feeding
Disease control Recruiting nowThis study is testing whether an experimental injection called HM15912 is safe and can help adults with short bowel syndrome intestinal failure. Participants will receive either the drug or a placebo for up to 13 months to see if it improves how their bodies absorb nutrients. The…
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New drug aims to free patients from IV dependence
Disease control Recruiting nowThis study is testing whether a new injectable drug called PJ009 can help people with short bowel syndrome reduce their need for intravenous (IV) nutrition. Researchers will compare PJ009 to a placebo in about 72 patients aged 14 and older over 36 weeks. The main goal is to see i…
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC
-
New hope for taming debilitating diarrhea in rare gut condition
Symptom relief Recruiting nowThis small, early-stage study is testing whether a drug called crofelemer can help adults with short bowel syndrome who have an ileostomy. The goal is to see if the drug can safely reduce severe diarrhea and the need for intravenous (IV) fluids and nutrition. Participants will ta…
Matched conditions: SHORT BOWEL SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Lindsey Russell, MD • Aim: Symptom relief
Last updated Mar 12, 2026 13:52 UTC
-
Researchers craft faster 'Life Gauge' for gut condition patients
Knowledge-focused Recruiting nowThis study aims to create a new, quicker questionnaire to measure quality of life for people with short bowel syndrome. Researchers will compare their new tool, which uses a simple disk format, to an existing, more complex questionnaire. The goal is to make it easier for doctors …
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC